Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.

Details

Serval ID
serval:BIB_C25A8B21E7DD
Type
Article: article from journal or magazin.
Collection
Publications
Title
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Journal
Pediatric Nephrology
Author(s)
Prévot A., Semama D.S., Tendron A., Justrabo E., Guignard J.P., Gouyon J.B.
ISSN
0931-041X
Publication state
Published
Issued date
2000
Peer-reviewed
Oui
Volume
14
Number
10-11
Pages
927-934
Language
english
Abstract
We previously developed a model of acute cyclosporine A (CsA)-induced vasomotor nephrotoxicity in rabbits. In the present study, we evaluated the role of endothelin (ET), angiotensin II (AII) and adenosine in this experimental model. All animals received CsA (25 mg/kg/day) for 5 days. Renal function parameters were first measured in a 30-min period, showing renal insufficiency in all animals. Then, rabbits were administered bosentan (10 mg/kg; antagonist of ET(AB) receptors), perindopril (20 microg/kg; angiotensin-converting enzyme inhibitor), or theophylline (1 mg/kg; adenosine receptor blocker at micromolar concentrations). After a 40-min equilibration period, renal function was assessed again for 30 min. Bosentan, perindopril and theophylline significantly reduced renal vascular resistance (-28+/-5%, -39+/-7% and -8+/-3%, respectively), and improved renal blood flow (+38+/-15%, +66+/-16% and +20+/-5%), glomerular filtration rate (+33+/-9%, +52+/-13% and +50+/-8%) and diuresis (+48+/-9%, +76+/-19% and +73+/-14%). Filtration fraction was unchanged with bosentan, decreased with perindopril (-10+/-9%) and increased with theophylline (+24+/-5%). The overall results suggest that ET, AII and adenosine are involved in the acute renal failure induced by CsA. We conclude that CsA administration for 5 days induced a vasomotor nephropathy with ET- and adenosine-mediated afferent arteriolar constriction as well as ET- and AII-mediated efferent arteriolar constriction.
Keywords
Acute Disease, Adenosine/pharmacology, Angiotensin II/pharmacology, Angiotensin-Converting Enzyme Inhibitors/pharmacology, Animals, Cyclosporine/blood, Endothelins/pharmacology, Glomerular Filtration Rate/drug effects, Immunosuppressive Agents/blood, Kidney/drug effects, Kidney/pathology, Kidney Diseases/chemically induced, Kidney Diseases/pathology, Male, Perindopril/pharmacology, Rabbits, Renal Circulation/drug effects, Theophylline/pharmacology, Vascular Resistance/drug effects, Water/pharmacology
Pubmed
Create date
20/07/2009 14:33
Last modification date
20/08/2019 16:37
Usage data